Loading market data...
Latest Top News
Centrum’s Q2 FY26: Revenue Rises, Loss Narrows Amid Strategic Infusions
Centrum Capital’s Q2 FY26 saw revenue rise to ₹823 crore, while net loss stood at ₹406.5 crore. Operational metrics improved, with EBITDA up 70% and EPS narrowing. Strategic equity infusions and fundraising efforts signal a turnaround plan, despite continued losses. The company aims for recovery through capital and efficiency.
Stay Ahead – Explore Now! Gujarat Inject Kerala Secures Large ₹144.9-Million Purchase Order






